ClinicalTrials.Veeva

Menu

Change of Immune Cell of ARDS Patients:an Observational Study

S

Southeast University, China

Status

Unknown

Conditions

ARDS
Intensive Care Medicine

Treatments

Other: taking blood sample

Study type

Observational

Funder types

Other

Identifiers

NCT02958748
20161106

Details and patient eligibility

About

To evaluate change of different immune cellsduring ARDS and its impact on prognosis.

Enrollment

60 estimated patients

Sex

All

Ages

16 to 90 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

①sign on the acknowledged

②Diagnosis with ARDS(The Berlin definition),onset within 48hours

Exclusion criteria

①diagnosis of hematological or immunological disease

②treatment with chemotherapy agents or corticosteroids within 6 months prior to or during the hospitalization.

Trial design

60 participants in 2 patient groups

ARDS
Description:
Patients admitted to ICU with diagnosis of ARDS,which happened in 48hours.
Treatment:
Other: taking blood sample
Control
Description:
Heathy vonlunteers
Treatment:
Other: taking blood sample

Trial contacts and locations

0

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems